Yeung, T.-L.; Tsai, C.C.; Leung, C.S.; Au Yeung, C.-L.; Thompson, M.S.; Lu, K.H.; Freedman, R.S.; Birrer, M.J.; Wong, K.-K.; Mok, S.C.
ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression. Cancers 2018, 10, 464.
https://doi.org/10.3390/cancers10120464
AMA Style
Yeung T-L, Tsai CC, Leung CS, Au Yeung C-L, Thompson MS, Lu KH, Freedman RS, Birrer MJ, Wong K-K, Mok SC.
ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression. Cancers. 2018; 10(12):464.
https://doi.org/10.3390/cancers10120464
Chicago/Turabian Style
Yeung, Tsz-Lun, Ching Chou Tsai, Cecilia S. Leung, Chi-Lam Au Yeung, Melissa S. Thompson, Karen H. Lu, Ralph S. Freedman, Michael J. Birrer, Kwong-Kwok Wong, and Samuel C. Mok.
2018. "ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression" Cancers 10, no. 12: 464.
https://doi.org/10.3390/cancers10120464
APA Style
Yeung, T.-L., Tsai, C. C., Leung, C. S., Au Yeung, C.-L., Thompson, M. S., Lu, K. H., Freedman, R. S., Birrer, M. J., Wong, K.-K., & Mok, S. C.
(2018). ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression. Cancers, 10(12), 464.
https://doi.org/10.3390/cancers10120464